🇺🇸

Broad Market

· monthly

US Pre-Market SEC Filings Roundup — August 25, 2026

The overnight filing set is dominated by M&A and insider activity, with the most critical development being NextEra Energy's voluntary supplemental disclosures for its $9B+ acquisition of Dominion Energy, which faces shareholder lawsuits threatening a September 3 vote. A second major M&A signal comes from Navitas Semiconductor's agreement to acquire Claros for up to $232.8 million, doubling its addressable market to $8B+ and positioning it in AI data center power management — a high-growth thematic. Insider activity is mixed but notable: the CEO of Prenetics Global bought ~$239K in stock at ~$21.40, a strong bullish signal for a micro-cap, while Procore Technologies saw multiple C-suite tax-withholding sales totaling ~$4.9M at ~$63, which is typical but heavy in volume. On the negative side, the CEO of Fold Holdings sold stock at ~$0.48-0.49, and Namib Minerals’ beneficial owner disclosed a dilutive share loan of up to 14M shares carrying 13% interest, creating overhang. Teekay Tankers awarded dividend equivalent rights, signaling a steady return of capital. XPeng and Vipshop both filed unremarkable 6-Ks. Period-over-period trends are sparse, but Molecular Partners showed a 28% YoY improvement in net loss to CHF -26.7M, a positive turn in cash burn. The overall tone is neutral-to-bullish on M&A and selected insider buys, with material risk from litigation and dilution in a few names.

42 high priority 8 medium 50 total filings
· daily

Global High-Priority Regulatory Events — August 24, 2026

This digest of 34 filings for August 24, 2026, reveals a pronounced bifurcation in corporate health: a cluster of distressed entities facing regulatory insolvency or delisting, while others execute strategic transactions like M&A and open offers. A primary theme is the wave of Nasdaq/NYSE American delisting actions targeting SPACs (Pantages Capital, Senmiao Technology, Northann Corp) and growth companies, signaling tighter exchange scrutiny amid market volatility. Conversely, mid-cap acquisitions and divestitures are prevalent, particularly in Indian industrials (Pavna Industries, Majestic Auto, HEG Limited), with buyers focusing on core businesses and unlocking value. The complete liquidation of the Hashdex Bitcoin ETF (DEFI) and the court-appointed receivership of Bubblr Inc. represent the two most extreme downside events, highlighting total capital loss scenarios. Capital allocation trends are defensive, with companies both cutting complexity (Pavna, Almondz Global) and seeking strategic growth (Martin Marietta, Blue Cloud Softech). Insider activity is minimal across filings, but management changes in HEG and Integrated Wellness signal strategic pivots. Overall, the period underscores a 'survival of the fittest' environment where regulatory compliance, strategic focus, and financial fortitude are paramount.

34 high priority 34 total filings
· daily

US SEC Filings Daily Market Digest — August 24, 2026

The August 24, 2026, filing stream reveals a market dominated by significant capital allocation events, strategic shifts, and mixed legal outcomes. Key themes include a wave of insider buying at Alibaba Group, signaling management confidence despite a major equity placement, and a notable 'going private' transaction for Utz Brands at a 91% premium. The SPAC sector shows continued stress, with YHN Acquisition I facing shareholder skepticism and Roman DBDR Acquisition Corp. II receiving a Nasdaq deficiency notice. Legal and regulatory developments are prominent, with mixed verdicts for Cytek Biosciences and Sable Offshore Corp. creating binary risk/reward scenarios. The energy and materials sector sees strategic divestitures, like Comstock Inc. selling its mining assets, while healthcare shows early-stage clinical progress from Precision BioSciences and Tiziana Life Sciences. Overall, the data points to a market where companies are actively managing their capital structures and legal exposures, with insider activity providing a clear signal of management conviction at Alibaba.

19 high priority 31 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 24, 2026

This pre-market digest covers 50 overnight SEC filings from August 23-24, 2026, revealing a market dominated by significant capital events and strategic shifts. The most impactful themes include a wave of going-private and M&A transactions (Utz Brands at a 91% premium, Modiv Industrial's deregistration, Callan JMB's asset acquisition), substantial insider buying at Alibaba ($5M CEO purchase) and 17 Education, contrasted with heavy secondary selling at Aveanna Healthcare. A notable SPAC sector stress is evident, with Roman DBDR facing Nasdaq delisting for low public holders and YHN Acquisition seeking a third extension amid high redemptions. Financial distress signals are flashing at BioXcel Therapeutics, which secured only a one-week debt extension. On the positive side, Aegon expanded its buyback by 150 million euros, and InterCure received a $77 million war damages settlement. Key period-over-period trends from the data show ConnectM Technology's revenue growing 24.2% YoY but with gross margin compression from 36.5% to 28.6%, while Holtec Nuclear's revenue declined 5.8% YoY. The mixed patent verdict for Cytek Biosciences ($56M award) and Sable Offshore's partial legal win create binary event risks. Overall, the filings suggest a market favoring cash returns and defensive positioning, with selective growth in AI-adjacent and rare disease sectors.

19 high priority 31 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 21, 2026

The August 21, 2026, filing cycle reveals a market bifurcated between aggressive capital-raising and strategic restructuring. A significant cluster of companies, including Applied Optoelectronics ($600M ATM), OS Therapies ($75M ATM), and Enova International ($301M securitization), are actively tapping equity and debt markets, signaling a high demand for growth or working capital. This is counterbalanced by a wave of corporate failures and restructurings, such as the termination of the BSTR/Cantor Equity Partners merger, the failed Mangoceuticals/Nuclea Energy deal, and the strategic review at NEXGEL. Insider activity is notably absent, with no major insider buying or selling detected across the 50 filings, suggesting a cautious or neutral stance from management. The most actionable themes are the refinancing of high-cost debt (Gray Media saving ~300 bps on $675M) and the emergence of distressed financing situations (Edgemode, Nexalin) that signal severe financial strain. The overall tone is one of strategic repositioning, with companies either fortifying balance sheets or facing existential challenges.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 21, 2026

This digest covers 50 filings from August 21, 2026, revealing a market bifurcated between aggressive corporate restructuring and a wave of micro-cap distress. The most critical theme is a deluge of Nasdaq non-compliance notices, with 14 companies receiving deficiency warnings for low bid prices, insufficient equity, or delinquent filings, signaling a potential wave of micro-cap delistings. Concurrently, there is significant M&A and restructuring activity, including a $180M SPAC merger for Everli Global, a major insolvency admission for Satiate Agri Ltd (₹6.27 Cr default), and the final deregistration of QVC Group post-bankruptcy. Insider activity was limited, but a notable promoter acquisition in Orissa Bengal Carrier and a related-party acquisition by KPI Green Energy highlight specific capital allocation moves. The overarching theme is one of cleansing: distressed micro-caps face existential threats while larger entities pursue strategic consolidation and new ventures, creating a high-risk, high-opportunity environment for event-driven investors.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 21, 2026

Today's filings reveal a market bifurcated between aggressive corporate restructuring and operational stress. The most significant themes are a wave of M&A activity facing execution hurdles (LivePerson, BSTR Holdings, Simulations Plus) and a sharp deterioration in credit quality at smaller financials (GBank Financial). On the positive side, several companies are executing strategic refinancings (Methanex, Jefferson Capital) and capital allocation shifts (News Corp buyback). Insider selling at Sea Ltd by multiple C-suite executives under 10b5-1 plans is a notable bearish signal for the tech sector. The data shows a clear pattern of revenue growth being offset by margin compression and rising interest costs across industrials and consumer-facing companies (Sysco, Dingdong). The upcoming week is catalyst-heavy with key shareholder votes on transformative M&A (LivePerson, Pasqal, Simulations Plus) that will determine the fate of several high-profile deals.

20 high priority 30 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 20, 2026

The August 20, 2026, filing batch reveals a market dominated by significant capital markets activity and strategic corporate restructuring. A major theme is the completion of Santander's transformative acquisition of Webster Financial, creating a $327 billion asset bank, while several other companies are aggressively refinancing or raising debt, including OneMain ($600M notes), Royal Caribbean ($1.25B notes), and Dynatrace ($1.25B exchangeable notes). Concurrently, there is a notable wave of corporate governance actions, including a hostile takeover defense at Better Home & Finance, a major divestiture by James Hardie ($980M), and multiple leadership transitions at firms like Jack in the Box and Ingredion. The data shows a clear bifurcation: large-cap firms are accessing debt markets on favorable terms to fund growth or refinance, while smaller companies like Nexalin Technology and InnSuites Hospitality are resorting to dilutive equity or debt-for-equity swaps to manage cash constraints. Insider activity is sparse in the filings, but the number of board resignations and appointments suggests a period of active governance recalibration across sectors.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 20, 2026

August 20, 2026, was a day of massive corporate restructuring, dominated by two mega-bank acquisitions—Banco Santander's $15B+ takeover of Webster Financial and Charter Communications' transformative merger with Cox Communications—and a surge in SPAC activity with both an IPO and a critical business combination vote, alongside a market-wide wave of bankruptcies and insolvencies. A clear portfolio-level trend emerges: a significant divergence between the US and Indian markets, with the US seeing high-profile M&A and delistings while Indian firms aggressively pursue mid-market consolidation and regulatory-driven insolvencies. Insider activity is minimal across the dataset, but management conviction is visible in several Indian acquisitions, notably Indo Borax's high-conviction open offer for Kronox Lab Sciences at a hefty 52% premium to the acquisition price. Key risks include the rapid liquidity burn at Nukkleus Inc. (stockholder equity plunging from +$42.5M to -$19.7M in one quarter) and the 47.4% preliminary redemption rate at RF Acquisition Corp II, threatening to gut its cash trust. Catalysts to watch include the rapid 3-month closing of the Indo Borax/Kronox deal and the September 18 hearing for the NDL Ventures-Hinduja Leyland merger. Despite a negative overall tilt due to delistings and insolvencies, pockets of opportunity exist in the Indian specialty chemicals (Indo Borax) and the US broadband sector under the new Cox-Charter entity.

48 high priority 48 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 20, 2026

Overnight SEC filings reveal a mixed but actionable landscape. Insider activity is notable: significant buying at Li Bang International and Chicago Atlantic BDC, while heavy selling at Cerebras Systems, Equity Residential, and Netlist signals caution. A major development is JBS's non-binding proposal to acquire the remaining ~18% of Pilgrim's Pride, implying a value of ~$28.49 per share, which could drive PPC shares. Knorex reported a sharp revenue decline of 44.2% YoY and a widening net loss, flagging operational distress. Office Properties Income Trust's emergence from bankruptcy with Redwood Capital's 18% stake and board rights presents a potential restructuring opportunity. AST SpaceMobile's broad insider awards suggest confidence in future growth. Overall, the data highlights selective opportunities in special situations and insider conviction, while warning of deteriorating fundamentals in some names.

50 high priority 50 total filings
· daily

US Material Events SEC 8-K Filings — August 19, 2026

The 50 filings reveal a dynamic market landscape with significant M&A activity, strategic financings, and leadership transitions. Key themes include a surge in SPAC-related transactions (Oceanhawk, Viking, Karman Line), aggressive capital raises via convertible notes (Datavault AI, Opendoor) and ATM offerings (FrontView, XCel), and notable M&A deals (Harte Hanks, Weave, Datavault AI). Period-over-period data shows mixed financial health: some companies like Ameresco reaffirm strong guidance, while others like Arrive AI face distress. Insider activity is limited but includes performance-based CEO grants (Unity, Envista) signaling alignment. Capital allocation trends show debt refinancing (Newell, Griffon) and balance sheet strengthening (Saratoga). Forward-looking catalysts include clinical trial readouts (Longeveron) and M&A closings (Destination XL). Overall, the market is active with both opportunities and risks, particularly in high-growth tech and SPAC sectors.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 19, 2026

This digest of 50 SEC filings from August 19, 2026, reveals a market sharply bifurcated between distressed situations and strategic M&A. A cluster of 10 SPAC filings, including a $200 million IPO (Karman Line) and several delistings (Artius II, Xos warrants), highlights the ongoing churn in the blank-check sector. The most critical developments are the near-completion of the $77/share acquisition of Forte Biosciences by argenx, a high-risk delisting notice for Skye Bioscience, and a massive $1.0 billion token deal for Flora Growth Corp. On the distressed side, three Indian companies (AGS Transact, Setubandhan, Zicom) are in active insolvency, while two iShares ETFs were voluntarily liquidated. Insider activity is notably absent across the filings, but forward-looking data points to several key catalysts, including shareholder votes and compliance deadlines. The overarching theme is capital allocation under pressure: companies are either aggressively pursuing transformative M&A, winding down, or fighting for survival.

50 high priority 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 19, 2026

This overnight filing cycle is dominated by a major M&A development in the protein sector, with JBS N.V. making a non-binding proposal to acquire the remaining ~18% of Pilgrim's Pride it does not own. The implied valuation offers no premium, creating a potential arbitrage opportunity but also signaling a lack of urgency from the buyer. Insider selling is the most prevalent theme, with notable disposals from executives at Roivant Sciences, Corpay, and Veradermics, suggesting management is taking profits at elevated levels. A significant governance battle is unfolding at Better Home & Finance, where the CEO's attempt to remove directors has led to a lawsuit, creating high uncertainty. On the positive side, a key regulatory condition (HSR waiting period) was cleared for argenx's acquisition of Forte Biosciences, moving that deal closer to completion. The filing set also includes a delisting notice for Skye Bioscience due to negative equity, and a large convertible note issuance by Datavault AI, indicating financial distress. Overall, the market is presented with a mix of high-stakes M&A, insider profit-taking, and corporate governance risks, with few clear bullish signals from operational results.

37 high priority 13 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 18, 2026

The August 18, 2026, filings reveal a market bifurcated between aggressive capital deployment and acute financial distress. A clear theme is the significant expansion of credit facilities and debt offerings by large-cap and mid-cap firms (e.g., Apollo Debt Solutions BDC, CCO Holdings, EXL, Martin Marietta), signaling a hunt for cheap capital to fund M&A and shareholder returns. Conversely, a cluster of micro-cap companies (XCF Global, Off The Hook YS, Avalon GloboCare) are resorting to highly dilutive, short-term financing with punitive terms, indicating severe liquidity crises. The technology and energy sectors show divergent paths: Cypherpunk Technologies made a bold, equity-based bet on Zcash mining, while TScan Therapeutics suffered a major partnership termination. Governance and accounting scandals are also prominent, with Netcapital's auditor resignation over an SEC fraud complaint and XTI Aerospace's CEO resignation amid an internal review, creating significant risk flags. Overall, the period is characterized by a 'haves vs. have-nots' dynamic, where access to capital is the primary differentiator.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 18, 2026

This digest covers 50 filings from August 18, 2026, revealing a market landscape dominated by corporate distress and restructuring. The most significant theme is a wave of insolvencies and liquidations, with 12 companies actively in CIRP or winding down, including high-materiality events at **TV Vision**, **Blue Blends**, **Simbhaoli Sugars**, and **Firsthand Technology Value Fund**. A secondary theme is the flurry of M&A activity, with 15 filings involving acquisitions, mergers, or open offers, ranging from small strategic buys (e.g., **DLF**'s ₹4.2 crore green power investment) to major control transactions (e.g., **Heubach Colorants**' 54.36% stake acquisition). Period-over-period data reveals severe financial deterioration across distressed entities, with **TV Vision**'s revenue collapsing 96.8% YoY and **Eureka Industries**' revenue falling to near zero. In contrast, a few strategic acquisitions show positive momentum, such as **Jubilant Ingrevia**'s investment in a high-growth electronics services firm. The overall sentiment is heavily negative, with 18 filings carrying a negative or mixed-negative sentiment, reflecting a market cleaning out weak balance sheets and non-viable business models. The most critical developments are the complete wind-down of **Firsthand Technology Value Fund** (SVVC) and the aggressive restructuring at **Blue Blends (India) Ltd**, which is canceling 97.3% of public shares, signaling a total wipeout for existing equity holders.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 18, 2026

The August 18, 2026 filing cycle reveals a market bifurcated between strong commodity-driven growth and acute distress in small-cap tech and healthcare. BHP Group's stellar FY2026 results (revenue +14.6% YoY, EBITDA +26.8%) underscore a robust commodity cycle, while Braskem's credit rating downgrade to Restricted Default and Netcapital's auditor resignation over a $13.9M revenue recognition issue highlight severe credit and governance risks. A wave of insider filings at Conexeu Sciences and KE Holdings shows passive ownership changes tied to corporate actions rather than active buying, offering limited bullish conviction. Capital allocation is mixed: Equinor and Novo Nordisk continue steady buybacks, while Gray Media's $750M refinancing reduces interest costs but increases leverage. The most actionable themes are the commodity super-cycle (BHP), the quantum computing revenue inflection at Infleqtion (+157% YoY), and the distressed debt/restructuring situations at Braskem and Sadot Group. Investors should monitor the late-filing cascade at XTI Aerospace, Royale Energy, and Selectis Health for potential accounting issues.

20 high priority 30 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 18, 2026

The overnight filing cycle was dominated by several high-severity events: a massive audit resignation and SEC fraud complaint at Netcapital, a Chapter 11 cancellation of equity at GoHealth, a credit rating downgrade to Restricted Default at Braskem, and a sharp revenue collapse at MOBIX LABS which is burning cash rapidly. Conversely, BHP Group reported a standout year with strong revenue (+14.6% YoY) and profit growth, while Haemonetics secured a potentially transformative non-exclusive supply deal with CSL Plasma. Insider activity was mixed: a significant 10% owner buy at Lifeway Foods and a director buy at Mobia Medical signal confidence, while C-suite selling at Marvell, AIRO Group, and MediaAlpha under 10b5-1 plans suggest routine pre-planned divestitures. A clear sector rotation theme emerged: commodity/industrial strength (BHP, copper/iron ore) contrasts with tech/service headwinds (uCloudlink, MOBIX). The M&A landscape is active with Datavault AI's acquisition of CyberCatch and activist pressure on Better Home & Finance Holding.

26 high priority 24 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 17, 2026

The August 17, 2026, filing batch reveals a market dominated by transformative M&A and significant capital structure maneuvers, with several multi-billion-dollar deals reshaping the industrial, real estate, and technology landscapes. The merger of AvalonBay and Equity Residential into Vivmark ($70B EV) and Madison Air's $5.4B acquisition of ebm-papst signal a strong appetite for scale and synergies, while TTM Technologies' $1.1B deal and Fulcrum/Slate Medicines' reverse merger highlight sector-specific consolidation. A notable undercurrent is financial stress, with several companies (Prairie Operating, Phoenix Energy, Abundia Global) securing high-cost or restrictive debt amendments, and a wave of CFO transitions (Centene, Aon, Enovix) creating leadership uncertainty. Insider activity was sparse but negative in one key instance (LiveRamp's say-on-pay rejection), while capital raises via debt (AMD $4.75B, MasTec $650M) and equity (Dare Bioscience, Dermata) point to active balance sheet management. The overall sentiment is cautiously positive for large-cap strategic moves but bearish for smaller, cash-constrained firms.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 17, 2026

This digest covers 46 filings from August 17, 2026, dominated by a wave of corporate distress and strategic realignment. The most critical theme is a surge in insolvencies and defaults, with Pradhin Limited, Vivimed Labs, Simbhaoli Sugars, TV Vision, and Dharan Infra-EPC all undergoing CIRP, while Mangalam Drugs shows a prolonged 10-month bank default. Concurrently, a major consolidation is underway in the real estate and behavioral health sectors, highlighted by the $70B merger of AvalonBay and Equity Residential into Vivmark Residential, and Universal Health Services' acquisition of Talkspace. Several companies are also facing Nasdaq delisting pressures, including Dermata Therapeutics, Nexalin Technology, and Talkspace (post-acquisition). On the positive side, there is significant M&A activity in the industrial and infrastructure space, with Lloyds Engineering and Lloyds Enterprises acquiring controlling stakes in SISCOL, and Manipal Health Enterprises expanding its hospital network. The data reveals a bifurcated market: capital is flowing into strategic consolidations and growth acquisitions, while heavily indebted or operationally challenged companies are entering resolution processes.

46 high priority 46 total filings
· daily

US SEC Filings Daily Market Digest — August 17, 2026

Today's filings reveal a market bifurcated between aggressive M&A and capital markets activity and a wave of operational distress. Notable M&A includes TTM Technologies' $1.1B acquisition of Epiq Solutions and LogicMark's merger with Langham Project, while several companies (Wellgistics, Ming Shing, Cosan) show severe revenue declines or losses. Late filings (NT 10-Q) from M2i Global, FDCTECH, Duos, and IWAC signal potential accounting or operational issues. Insider activity is limited, but Dreamland's CEO increased her stake, and Cosan's CFO departure adds to its restructuring narrative. Capital allocation trends show a mix of warrant exercises (Dogness), convertible note raises (Wellgistics), and a SPAC IPO (Gravity Acquisition). Sector themes include a focus on liquidity and restructuring in energy/industrial, continued biotech volatility, and passive ETF dominance in 13F filings. Key catalysts include Centene's CFO transition, Interactive Strength's special meeting, and Bleichroeder's business combination vote.

17 high priority 33 medium 50 total filings